CBmed is a public-private-partnership biomarker research company funded by the Austrian COMET programme for excellent technologies.
and start of 25 biomarker COMET research projects in Graz and Vienna
of BBMRI-ERIC in May 2016
Foundation of the AMBRA (advanced medical biomarker research) PhD programme by CBmed in cooperation with the Medical University of Graz.
and 13 contract research projects with over 50 international partners on 4 continents in industry and academia.
and successfully started with 11 focused research projects for precision medicine
with global players in Korea, Japan and big pharma
with outstanding results for clinical translation and new products together with industry
in personalised medicine through combining cutting-edge technologies with international and interdisciplinary expertise